Search | VHL Regional Portal

Barrett's esophagus: proton pump inhibitors and chemoprevention II.

Richter, Joel E; Penagini, Roberto; Tenca, Andrea; Pohl, Daniel; Dvorak, Katerina; Goldman, Aaron; Savarino, Edoardo; Zentilin, Patrizia; Savarino, Vincenzo; Watson, Joshua T; Wong, Roy K H; Pace, Fabio; Casini, Valentina; Peura, David A; Herzig, Shoshana Joy; Kamiya, Takeshi; Pelosini, Iva; Scarpignato, Carmelo; Armstrong, David; DeVault, Kenneth R; Bechi, Paolo; Taddei, Antonio; Freschi, Giancarlo; Ringressi, Maria Novella; Degli'Innocenti, Duccio Rossi; Castiglione, Francesca; Masini, Emmanuella; Hunt, Richard H.

Ann N Y Acad Sci ; 1232: 114-39, 2011 Sep.

Article in English | MEDLINE | ID: mdl-21950810

ABSTRACT

The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

Subject(s)

Barrett Esophagus/drug therapy , Chemoprevention , Proton Pump Inhibitors/therapeutic use , Humans , Monitoring, Physiologic , Treatment Outcome

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL